Fundraising Fox

GPN Vaccines

Wilmington, US · Founded 2025 · Delaware corporation · 3 known investors

Biotech

Founders & leadership

GPN Vaccines was founded in 2025 by Timothy Hirst.

TH
Timothy HirstFounder
JS
James SelkirkExecutive

Investors · 3

Forepont Capital Partnersreported · 2 sourcesNew York
Kern Capital, LLCreported · 2 sourcesLarkspur · $5M – $15M
Shearwater Capitalreported$200K – $5M

Funding

SEC filings, press & company announcements

$3.5M disclosed across 1 of 3 rounds · 2024–2025

▶$3.5MraisedJan 2026 · 63 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Timothy HirstExecutive Officer, Director
  • James SelkirkExecutive Officer
Offering amount
$10M
Amount sold
$3.5M
Minimum investment
$228
First sale
Dec 2025
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Adelaide biotech GPN Vaccines secures $18 million to advance life-saving vaccine - AUScelerate SA » AUScelerate SAausceleratesa.org · Jun 2024Aussie start-up GPN Vaccines scores $300m valuation from funding round led by Forepont Capital, Kern Capitalafr.com · Jun 2024GPN Vaccines Closes $18M Series B1 Round - GPN Vaccinesgpnvaccines.com · Jun 2024GPN Vaccines Awarded CUREator Funding - GPN Vaccinesgpnvaccines.com · May 2024GPN Vaccines raises $1.1M - GPN Vaccinesgpnvaccines.com · Jan 2019

Frequently asked questions

Who founded GPN Vaccines?
GPN Vaccines was founded by Timothy Hirst in 2025.
Who are GPN Vaccines's investors?
GPN Vaccines's investors include Forepont Capital Partners, Kern Capital, LLC, Shearwater Capital.
How much funding has GPN Vaccines raised?
GPN Vaccines has disclosed $3.5M raised across 1 of its 3 known rounds.
Where is GPN Vaccines headquartered?
GPN Vaccines is headquartered in Wilmington, US.